The details and results for this trial are still pending
Braz J Plant Physiol
React state, useEffect , ship it
So, why wait
Without clinical data, it is challenging to ascertain the potential short-term or long-term adverse effects of BPC-157
In closely split votes, the panel backed BPC-157, KPV, TB-500, MOTS-c, epitalon, and semax for a range of proposed uses including wound healing, ulcerative colitis, weight loss, migraines, pain, and insomnia, while rejecting emideltide for opioid withdrawal and sleep disorders